TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer
about
Genetics and genomics of radiotherapy toxicity: towards predictionExploiting biological and physical determinants of radiotherapy toxicity to individualize treatmentIndividual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients.Can the severity of normal tissue damage after radiation therapy be predicted?Genetic predictors of long-term toxicities after radiation therapy for breast cancer.Genetic influences on hand osteoarthritis in Finnish women--a replication study of candidate genesGenetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer.Association of XRCC1 and XRCC3 gene haplotypes with the development of radiation-induced fibrosis in patients with nasopharyngeal carcinomaTesticular cancer survivorship: research strategies and recommendations.Association of single nucleotide polymorphisms in the genes ATM, GSTP1, SOD2, TGFB1, XPD and XRCC1 with risk of severe erythema after breast conserving radiotherapy.Individual patient data meta-analysis shows no association between the SNP rs1800469 in TGFB and late radiotherapy toxicity.A bioinformatics filtering strategy for identifying radiation response biomarker candidates.Association of genes of protease-antiprotease balance pathway to lung function and emphysema subtypes.TGFβ1 Polymorphisms Predict Distant Metastasis-Free Survival in Patients with Inoperable Non-Small-Cell Lung Cancer after Definitive Radiotherapy.No association between TGFB1 polymorphisms and late radiotherapy toxicity: a meta-analysis.Gene expression profiling of human dermal fibroblasts exposed to bleomycin sulphate does not differentiate between radiation sensitive and control patients.No association between SNPs regulating TGF-β1 secretion and late radiotherapy toxicity to the breast: results from the RAPPER study.Identification of SNPs associated with susceptibility for development of adverse reactions to radiotherapyThe association between TGF-β1 polymorphisms and radiation pneumonia in lung cancer patients treated with definitive radiotherapy: a meta-analysis.Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy.SNPs in DNA repair or oxidative stress genes and late subcutaneous fibrosis in patients following single shot partial breast irradiationCan risk of radiotherapy-induced normal tissue complications be predicted from genetic profiles?The late radiotherapy normal tissue injury phenotypes of telangiectasia, fibrosis and atrophy in breast cancer patients have distinct genotype-dependent causes.Cancer-related fatigue: links with inflammation in cancer patients and survivors.Analysis of single nucleotide polymorphisms and radiation sensitivity of the lung assessed with an objective radiologic endpoinCancer pharmacogenomics: role of DNA repair genetic polymorphisms in individualizing cancer therapy.Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype.Genetic variations in DNA repair genes, radiosensitivity to cancer and susceptibility to acute tissue reactions in radiotherapy-treated cancer patients.Can cutaneous telangiectasiae as late normal-tissue injury predict cardiovascular disease in women receiving radiotherapy for breast cancer?Biologically conformal treatment: biomarkers and functional imaging in radiation oncology.Single nucleotide polymorphisms, apoptosis, and the development of severe late adverse effects after radiotherapy.Cytokine gene polymorphisms and fatigue in breast cancer survivors: early findings.Genes involved in innate immunity associated with asbestos-related fibrotic changesCurrent concepts in clinical radiation oncology.Risk of radiation-induced subcutaneous fibrosis in relation to single nucleotide polymorphisms in TGFB1, SOD2, XRCC1, XRCC3, APEX and ATM--a study based on DNA from formalin fixed paraffin embedded tissue samples.Radiogenomics: A systems biology approach to understanding genetic risk factors for radiotherapy toxicity?Silibinin prevents prostate cancer cell-mediated differentiation of naïve fibroblasts into cancer-associated fibroblast phenotype by targeting TGF β2.Genetic susceptibility to cutaneous radiation injury.Biologically effective dose and breast cancer conservative treatment: is duration of radiation therapy really important?Among 45 variants in 11 genes, HDM2 promoter polymorphisms emerge as new candidate biomarker associated with radiation toxicity.
P2860
Q21183971-F1B0C31F-14DC-476B-B4AE-D96654F32232Q26849735-BB26BEF7-1F6F-4E1C-AA49-F037B7B546C8Q31116483-3AFF652E-8699-441E-82B6-5553C55B5DFDQ33262241-24F457C1-E83B-4A5E-AE02-541ED896FF6AQ33306558-C8841B00-1E2F-4E3B-AD4E-DE0496730429Q33604814-FB96EE23-2632-441E-98FD-AA59E2DB1D79Q33682155-14C581E6-2193-4B87-BBEF-F0509F080401Q33733745-A736C24B-84A8-40CE-8F39-596D82A881C3Q34039684-6F4B8FF8-C12D-45F1-BF65-F4768ED9C6EBQ34248451-6CE7C431-184E-4445-AF6C-A15B96A26887Q34314677-F6788DD9-892E-408F-BB91-C98B4B9FDCD6Q34328033-3FDA4F18-82DE-45FE-9A4B-28F6352252CBQ34756328-83DEE986-9362-4C9D-B46E-2135F9BC3FBAQ34804626-E6115A41-4232-44A8-A479-F500871B2505Q35018658-F09658A8-1653-4614-981B-2E44CFB15015Q35023605-C2CA2ADD-56DA-4C7A-8C17-91BECF8BE3C9Q35061078-92424339-51F8-47B9-919C-F5FBFEF63813Q35084218-2219C627-026B-4AE0-9E14-7125AE7AC344Q35123851-299AD7E4-CD65-4878-A8A3-ADE62E7EEA5FQ35273018-AE836038-ABA5-46AD-AED5-1DC7AC1304F1Q35773004-58129402-3B55-4C42-823C-CB9CF3C5098AQ36332992-5EFE651A-98FA-414C-8C80-F127D8AF7683Q36610079-6049D2E8-67F6-4F9B-9973-3B71535AD658Q36779251-C2291E66-CCFF-4ABB-B9EF-A4EBD0A7E379Q36813677-43223C51-BD2B-4853-9EF4-A76A0B754300Q37031517-9E96D386-E9E2-4549-847E-1AC79EF07743Q37162103-3ED1E1A6-6B00-4E7A-9F83-F2476B88440AQ37196316-43278408-4521-46A6-B268-7A0E49482B8AQ37287532-2B997645-B3F1-4031-8ED2-4A1F7FC87873Q37298667-F586C8EA-BFEF-4AD3-BE4D-440182D83510Q37408593-B68AF53B-29AC-4DB8-BD99-77FF16545547Q37440427-4B650ACF-EA82-4845-A0F7-00AB7547366EQ37465454-619E8185-F038-4657-8E58-EB3B41FD2051Q37603804-B9AA9C0D-8E8C-4972-BB55-1D858EB1BF8FQ38436110-B4F70B65-7382-4F52-A83A-C9CE372B419AQ38761174-7A1C5D61-7E91-484C-81B8-B6ABEBB64B5FQ39016642-8766E6D0-2594-4AED-A198-00FB125A6663Q39017652-89CE8B35-9BA1-47E5-B860-C6B83BAA4FB2Q43775129-4EED172E-F0D4-4EBB-9AF7-05DCAD4AF36EQ54393867-902F8E2F-A821-4AFD-85AA-35BD96003108
P2860
TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer
description
article
@en
im April 2005 veröffentlicher wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2005
@uk
name
TGFB1 polymorphisms are associ ...... herapy for early breast cancer
@en
TGFB1 polymorphisms are associ ...... herapy for early breast cancer
@nl
type
label
TGFB1 polymorphisms are associ ...... herapy for early breast cancer
@en
TGFB1 polymorphisms are associ ...... herapy for early breast cancer
@nl
prefLabel
TGFB1 polymorphisms are associ ...... herapy for early breast cancer
@en
TGFB1 polymorphisms are associ ...... herapy for early breast cancer
@nl
P2093
P50
P1476
TGFB1 polymorphisms are associ ...... herapy for early breast cancer
@en
P2093
Janis Homewood
Jens Overgaard
John Yarnold
Judith Bliss
Roger Owen
P356
10.1016/J.RADONC.2004.12.012
P577
2005-04-01T00:00:00Z